Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs, atezolizumab and bevacizumab, as the first treatment for people with advanced non-squamous non-small cell lung cancer that has a high number of genetic mutations. The goal was to see if this drug pair could slow down cancer growth. Th…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 17, 2026 04:32 UTC
-
Lung cancer & COVID: new study tracks immune response in nearly 2,000 patients
Knowledge-focused CompletedThis study looked at nearly 2,000 adults with lung cancer who caught COVID-19. Researchers collected medical records and blood tests to understand how their immune systems responded. They also checked antibody levels 6 months after COVID vaccination. The goal was to learn more ab…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC